APO RESEARCH · REPORT
Normal Saline for Parenteral Use
Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
Product & engineering
Understand the product.
Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
Selected research
Industry Research
Normal Saline for Parenteral Use Industry Research Report 2026
Market perspective
Normal saline is a mixture of salt and water. It is called normal because its salt concentration is similar to tears, blood and other body fluids (0.9% saline). It is also called isotonic solution. It has a number of uses in medicine. By injection into a vein it is used to treat dehydration such as from gastroenteritis and diabetic ketoacidosis. It is also used to dilute other medications to be given by injection.
This report studies Normal Saline for Parenteral Use market in hospital and clinics, and usually refers to Sodium Chloride Injection
At present, Baxter, Kelun Group, B. Braun, Fresenius Kabi and SSY Group are the top five manufacturers of gastrointestinal saline in the world, with a total market share of more than 45%.They are also the world's largest companies by sales.
Read the full market overview
Report Scope
This report quantifies the global Normal Saline for Parenteral Use market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Normal Saline for Parenteral Use Market by Company
Baxter
Pfizer
B. Braun
ICU Medical
Fresenius Kabi
Otsuka
Kelun Group
CR Double-Cran
SSY Group
Cisen Pharmaceutical
Denis Chem Lab Limited
Shree Krishnakeshav Laboratories
Pharmally International
Normal Saline for Parenteral Use Segment by Type
Flexible Bag
Plastic Bottles
Glass Bottles
Normal Saline for Parenteral Use Segment by Application
Intramuscular Injection
Intravenous Injection
Others
Normal Saline for Parenteral Use Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Normal Saline for Parenteral Use market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Normal Saline for Parenteral Use and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Normal Saline for Parenteral Use.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Normal Saline for Parenteral Use manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Normal Saline for Parenteral Use by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Normal Saline for Parenteral Use in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Flexible Bag
- Plastic Bottles
- Glass Bottles
Applications
- Intramuscular Injection
- Intravenous Injection
- Others
Companies covered
- Baxter
- Pfizer
- B. Braun
- ICU Medical
- Fresenius Kabi
- Otsuka
- Kelun Group
- CR Double-Cran
- SSY Group
- Cisen Pharmaceutical
- Denis Chem Lab Limited
- Shree Krishnakeshav Laboratories
- Pharmally International
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Normal Saline for Parenteral Use Market Size (2021-2032)
- 2.2.2 Global Normal Saline for Parenteral Use Sales (2021-2032)
- 2.2.3 Global Normal Saline for Parenteral Use Market Average Price (2021-2032)
- 2.3 Normal Saline for Parenteral Use by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Flexible Bag
- 2.3.3 Plastic Bottles
- 2.3.4 Glass Bottles
- 2.4 Normal Saline for Parenteral Use by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Intramuscular Injection
- 2.4.3 Intravenous Injection
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Normal Saline for Parenteral Use Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Normal Saline for Parenteral Use Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Normal Saline for Parenteral Use Revenue of Manufacturers (2021-2026)
- 3.4 Global Normal Saline for Parenteral Use Average Price by Manufacturers (2021-2026)
- 3.5 Global Normal Saline for Parenteral Use Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Normal Saline for Parenteral Use, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Normal Saline for Parenteral Use, Product Type & Application
- 3.8 Global Manufacturers of Normal Saline for Parenteral Use, Established Date
- 3.9 Global Normal Saline for Parenteral Use Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Baxter
- 4.1.1 Baxter Company Information
- 4.1.2 Baxter Business Overview
- 4.1.3 Baxter Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Baxter Normal Saline for Parenteral Use Product Portfolio
- 4.1.5 Baxter Recent Developments
- 4.2 Pfizer
- 4.2.1 Pfizer Company Information
- 4.2.2 Pfizer Business Overview
- 4.2.3 Pfizer Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Pfizer Normal Saline for Parenteral Use Product Portfolio
- 4.2.5 Pfizer Recent Developments
- 4.3 B. Braun
- 4.3.1 B. Braun Company Information
- 4.3.2 B. Braun Business Overview
- 4.3.3 B. Braun Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 B. Braun Normal Saline for Parenteral Use Product Portfolio
- 4.3.5 B. Braun Recent Developments
- 4.4 ICU Medical
- 4.4.1 ICU Medical Company Information
- 4.4.2 ICU Medical Business Overview
- 4.4.3 ICU Medical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 ICU Medical Normal Saline for Parenteral Use Product Portfolio
- 4.4.5 ICU Medical Recent Developments
- 4.5 Fresenius Kabi
- 4.5.1 Fresenius Kabi Company Information
- 4.5.2 Fresenius Kabi Business Overview
- 4.5.3 Fresenius Kabi Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Fresenius Kabi Normal Saline for Parenteral Use Product Portfolio
- 4.5.5 Fresenius Kabi Recent Developments
- 4.6 Otsuka
- 4.6.1 Otsuka Company Information
- 4.6.2 Otsuka Business Overview
- 4.6.3 Otsuka Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Otsuka Normal Saline for Parenteral Use Product Portfolio
- 4.6.5 Otsuka Recent Developments
- 4.7 Kelun Group
- 4.7.1 Kelun Group Company Information
- 4.7.2 Kelun Group Business Overview
- 4.7.3 Kelun Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Kelun Group Normal Saline for Parenteral Use Product Portfolio
- 4.7.5 Kelun Group Recent Developments
- 4.8 CR Double-Cran
- 4.8.1 CR Double-Cran Company Information
- 4.8.2 CR Double-Cran Business Overview
- 4.8.3 CR Double-Cran Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CR Double-Cran Normal Saline for Parenteral Use Product Portfolio
- 4.8.5 CR Double-Cran Recent Developments
- 4.9 SSY Group
- 4.9.1 SSY Group Company Information
- 4.9.2 SSY Group Business Overview
- 4.9.3 SSY Group Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 SSY Group Normal Saline for Parenteral Use Product Portfolio
- 4.9.5 SSY Group Recent Developments
- 4.10 Cisen Pharmaceutical
- 4.10.1 Cisen Pharmaceutical Company Information
- 4.10.2 Cisen Pharmaceutical Business Overview
- 4.10.3 Cisen Pharmaceutical Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cisen Pharmaceutical Normal Saline for Parenteral Use Product Portfolio
- 4.10.5 Cisen Pharmaceutical Recent Developments
- 4.11 Denis Chem Lab Limited
- 4.11.1 Denis Chem Lab Limited Company Information
- 4.11.2 Denis Chem Lab Limited Business Overview
- 4.11.3 Denis Chem Lab Limited Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Denis Chem Lab Limited Normal Saline for Parenteral Use Product Portfolio
- 4.11.5 Denis Chem Lab Limited Recent Developments
- 4.12 Shree Krishnakeshav Laboratories
- 4.12.1 Shree Krishnakeshav Laboratories Company Information
- 4.12.2 Shree Krishnakeshav Laboratories Business Overview
- 4.12.3 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Shree Krishnakeshav Laboratories Normal Saline for Parenteral Use Product Portfolio
- 4.12.5 Shree Krishnakeshav Laboratories Recent Developments
- 4.13 Pharmally International
- 4.13.1 Pharmally International Company Information
- 4.13.2 Pharmally International Business Overview
- 4.13.3 Pharmally International Normal Saline for Parenteral Use Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Pharmally International Normal Saline for Parenteral Use Product Portfolio
- 4.13.5 Pharmally International Recent Developments
5 Global Normal Saline for Parenteral Use Market Scenario by Region
- 5.1 Global Normal Saline for Parenteral Use Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Normal Saline for Parenteral Use Sales by Region: 2021-2032
- 5.2.1 Global Normal Saline for Parenteral Use Sales by Region: 2021-2026
- 5.2.2 Global Normal Saline for Parenteral Use Sales by Region: 2027-2032
- 5.3 Global Normal Saline for Parenteral Use Revenue by Region: 2021-2032
- 5.3.1 Global Normal Saline for Parenteral Use Revenue by Region: 2021-2026
- 5.3.2 Global Normal Saline for Parenteral Use Revenue by Region: 2027-2032
- 5.4 North America Normal Saline for Parenteral Use Market Facts & Figures by Country
- 5.4.1 North America Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Normal Saline for Parenteral Use Sales by Country (2021-2032)
- 5.4.3 North America Normal Saline for Parenteral Use Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Normal Saline for Parenteral Use Market Facts & Figures by Country
- 5.5.1 Europe Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Normal Saline for Parenteral Use Sales by Country (2021-2032)
- 5.5.3 Europe Normal Saline for Parenteral Use Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Normal Saline for Parenteral Use Market Facts & Figures by Country
- 5.6.1 Asia Pacific Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Normal Saline for Parenteral Use Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Normal Saline for Parenteral Use Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Normal Saline for Parenteral Use Market Facts & Figures by Country
- 5.7.1 South America Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Normal Saline for Parenteral Use Sales by Country (2021-2032)
- 5.7.3 South America Normal Saline for Parenteral Use Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Normal Saline for Parenteral Use Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Normal Saline for Parenteral Use Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Normal Saline for Parenteral Use Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Normal Saline for Parenteral Use Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Normal Saline for Parenteral Use Sales by Type (2021-2032)
- 6.1.1 Global Normal Saline for Parenteral Use Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Normal Saline for Parenteral Use Sales Market Share by Type (2021-2032)
- 6.2 Global Normal Saline for Parenteral Use Revenue by Type (2021-2032)
- 6.2.1 Global Normal Saline for Parenteral Use Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Normal Saline for Parenteral Use Revenue Market Share by Type (2021-2032)
- 6.3 Global Normal Saline for Parenteral Use Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Normal Saline for Parenteral Use Sales by Application (2021-2032)
- 7.1.1 Global Normal Saline for Parenteral Use Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Normal Saline for Parenteral Use Sales Market Share by Application (2021-2032)
- 7.2 Global Normal Saline for Parenteral Use Revenue by Application (2021-2032)
- 7.2.1 Global Normal Saline for Parenteral Use Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Normal Saline for Parenteral Use Revenue Market Share by Application (2021-2032)
- 7.3 Global Normal Saline for Parenteral Use Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Normal Saline for Parenteral Use Value Chain Analysis
- 8.1.1 Normal Saline for Parenteral Use Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Normal Saline for Parenteral Use Production Mode & Process
- 8.2 Normal Saline for Parenteral Use Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Normal Saline for Parenteral Use Distributors
- 8.2.3 Normal Saline for Parenteral Use Customers
9 Global Normal Saline for Parenteral Use Analyzing Market Dynamics
- 9.1 Normal Saline for Parenteral Use Industry Trends
- 9.2 Normal Saline for Parenteral Use Industry Drivers
- 9.3 Normal Saline for Parenteral Use Industry Opportunities and Challenges
- 9.4 Normal Saline for Parenteral Use Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst